摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(3R,7aR)-3-(trichloromethyl)-7a-((3,6,7-trimethoxyphenanthren-9-yl)methyl)tetrahydropyrrolo[1,2-c]oxazol-1(3H)-one | 1397943-62-2

中文名称
——
中文别名
——
英文名称
(3R,7aR)-3-(trichloromethyl)-7a-((3,6,7-trimethoxyphenanthren-9-yl)methyl)tetrahydropyrrolo[1,2-c]oxazol-1(3H)-one
英文别名
(3R,7aR)-3-trichloromethyl-7a-(3,6,7-trimethoxy-phenanthren-9-ylmethyl)-tetrahydro-pyrrolo[1,2-c]oxazol-1-one;(3R,7aR)-3-(trichloromethyl)-7a-[(3,6,7-trimethoxyphenanthren-9-yl)methyl]-3,5,6,7-tetrahydropyrrolo[1,2-c][1,3]oxazol-1-one
(3R,7aR)-3-(trichloromethyl)-7a-((3,6,7-trimethoxyphenanthren-9-yl)methyl)tetrahydropyrrolo[1,2-c]oxazol-1(3H)-one化学式
CAS
1397943-62-2
化学式
C25H24Cl3NO5
mdl
——
分子量
524.828
InChiKey
URTUYRFKAJKHTK-ISKFKSNPSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    6.7
  • 重原子数:
    34
  • 可旋转键数:
    5
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.4
  • 拓扑面积:
    57.2
  • 氢给体数:
    0
  • 氢受体数:
    6

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    (3R,7aR)-3-(trichloromethyl)-7a-((3,6,7-trimethoxyphenanthren-9-yl)methyl)tetrahydropyrrolo[1,2-c]oxazol-1(3H)-one乙酰氯 作用下, 以 甲醇 为溶剂, 反应 48.0h, 以72%的产率得到(R)-2-(3,6,7-trimethoxy-phenanthren-9-ylmethyl)-pyrrolidine-2-carboxylic acid methyl ester
    参考文献:
    名称:
    Design, synthesis, and evaluation of a water-soluble antofine analogue with high antiproliferative and antitumor activity
    摘要:
    New water soluble antofine C-13a analogues were designed, synthesized, and evaluated for antiproliferative activity against cancer cells. Particularly, (-)-(R)-13a-hydroxymethylantofine ((-)-(R)-4b) demonstrated notable growth inhibition against a panel of human cancer cell lines. This growth inhibition was associated with the arrest of the cell cycle in the G0/G1 phases and suppression of mTOR signaling in human lung A549 cancer cells. Compound (-)-(R)-4b also overcame paclitaxel-resistance in human lung cancer cells (A549-Pa) by suppressing P-glycoprotein expression. Furthermore, compound (-)-(R)-4b significantly inhibited the tumor growth of A549 and A549-Pa xenografts in a nude mouse model, which suggests it is a promising novel antitumor agent with sufficient aqueous solubility. (C) 2012 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2012.11.039
  • 作为产物:
    参考文献:
    名称:
    Enantioselective Approach to 13a-Methylphenanthroindolizidine Alkaloids
    摘要:
    The first enantioselective approach to 13a-methylphenanthroindolizidine alkaloids is reported, featuring an efficient stereoselective Seebach's alkylation and Pictet-Spengler cyclization. The proposed and other three most probable structures were ruled out, indicating hypoestestatin 1 needs further assignment.
    DOI:
    10.1021/jo3012122
点击查看最新优质反应信息

文献信息

  • Enantioselective Approach to 13a-Methylphenanthroindolizidine Alkaloids
    作者:Bo Su、Chunlong Cai、Qingmin Wang
    DOI:10.1021/jo3012122
    日期:2012.9.21
    The first enantioselective approach to 13a-methylphenanthroindolizidine alkaloids is reported, featuring an efficient stereoselective Seebach's alkylation and Pictet-Spengler cyclization. The proposed and other three most probable structures were ruled out, indicating hypoestestatin 1 needs further assignment.
  • Design, synthesis, and evaluation of a water-soluble antofine analogue with high antiproliferative and antitumor activity
    作者:Yongseok Kwon、Jayoung Song、Boeun Lee、Jinkyung In、Hohyun Song、Hwa-Jin Chung、Sang Kook Lee、Sanghee Kim
    DOI:10.1016/j.bmc.2012.11.039
    日期:2013.2
    New water soluble antofine C-13a analogues were designed, synthesized, and evaluated for antiproliferative activity against cancer cells. Particularly, (-)-(R)-13a-hydroxymethylantofine ((-)-(R)-4b) demonstrated notable growth inhibition against a panel of human cancer cell lines. This growth inhibition was associated with the arrest of the cell cycle in the G0/G1 phases and suppression of mTOR signaling in human lung A549 cancer cells. Compound (-)-(R)-4b also overcame paclitaxel-resistance in human lung cancer cells (A549-Pa) by suppressing P-glycoprotein expression. Furthermore, compound (-)-(R)-4b significantly inhibited the tumor growth of A549 and A549-Pa xenografts in a nude mouse model, which suggests it is a promising novel antitumor agent with sufficient aqueous solubility. (C) 2012 Elsevier Ltd. All rights reserved.
查看更多